Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Jingjia Medical Technology, commonly known as Jingjia Medical, is a specialized medical device company based in China that focuses on advanced solutions for diabetes management. The company is recognized for developing the Equil patch insulin pump, a tubeless and lightweight wearable device that provides precise basal and bolus insulin delivery. As a core subsidiary of MicroTech Medical, Jingjia Medical plays a vital role in the research, development, and large-scale manufacturing of insulin delivery systems and continuous glucose monitoring (CGM) technologies. Their product portfolio aims to integrate monitoring and delivery into a seamless closed-loop ecosystem to improve glycemic control for patients. With certifications such as the CE mark, Jingjia Medical's products are distributed across international markets, establishing the firm as a key innovator in the global metabolic disease device sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jingjia Medical.